October 2019 Neurotech news with Jim and Jen of Neurotech Reports

Published: Oct. 22, 2019, 2:41 p.m.

Top 3 takeaways

  1. Developments in the spinal cord stimulation market for pain  heat up with regulatory approval of 2 new devices for the treatment of chronic pain.
  2. Medtronic faces competition as Axonics enters the market with their sacral nerve stimulation device for fecal incontinence.
  3. Two major announcement for the treatment of paralysis due to SCI; one from DARPA and the other from European start-up venture, GTX medical